TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Creo Medical ( (GB:CREO) ) just unveiled an announcement.
Creo Medical Group plc has published its 2024 Annual Report and Accounts along with the Notice of its Annual General Meeting (AGM) on its website. The AGM is scheduled for 26 June 2025, where shareholders are encouraged to vote by proxy due to potential unforeseen circumstances. This announcement underscores the company’s commitment to transparency and shareholder engagement, while also highlighting its strategic focus on minimally invasive surgical endoscopy for cancer patients.
More about Creo Medical
Creo Medical Group plc is a medical device company specializing in the development and commercialization of minimally invasive electrosurgical devices. The company focuses on improving patient outcomes through its advanced energy technology, CROMA powered by Kamaptive, which enhances surgical capabilities and patient outcomes by integrating multi-modal energy sources for procedures such as resection, dissection, coagulation, and ablation.
Average Trading Volume: 1,703,705
Technical Sentiment Signal: Sell
Current Market Cap: £56.72M
Learn more about CREO stock on TipRanks’ Stock Analysis page.